✦ LIBER ✦

Pharmacokinetic and safety interactions between a novel PDE9 inhibitor, PF-04447943, and donepezil in healthy volunteers

✍ Scribed by Nicholas, Timothy; Park, Yo-sub; Choo, Heng Wee; Plotka, Anna; Martin, William; Martin, David; Schwam, Elias

Book ID: 123572469
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 54 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.05.2258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and pharmacokinetics of PF-044479

Safety and pharmacokinetics of PF-04447943, a PDEA inhibitor, in single and multiple dose Phase 1 studies in healthy volunteers

✍ Rebecca M. Evans; Timothy Nicholas; Vu Le; Ruolun Qiu; William Martin; David Mar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

PF-04447943, a novel PDE9A inhibitor, in

PF-04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: Translation from non-clinical species to healthy human volunteers

✍ Nicholas, Timothy; Evans, Rebecca; Styren, Scot; Qiu, Ruolun; Wang, Ellen Q.; Ne 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Pharmacokinetic Interactions between The

Pharmacokinetic Interactions between Theophylline and Prulifloxacin in Healthy Volunteers

✍ C. Fattore, G. Cipolla, G. Gatti, A. Bartoli, G. Orticelli, R. Picollo, L. Mille 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 261 KB

Safety, tolerability and pharmacokinetic

Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects

✍ Bo-Hyung Kim; Hyeong-Seok Lim; Jae-Yong Chung; Jung-Ryul Kim; Kyoung Soo Lim; Do 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

M1872 Evaluation of Pharmacokinetic Inte

M1872 Evaluation of Pharmacokinetic Interaction Between Esomeprazole and AZD3355, a Novel Reflux Inhibitor, in Healthy Volunteers

✍ Niazi, Mohammad; Silberg, Debra G.; Adler, John; Denison, Hans 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Multiple-Dose Pharmacokinetics and Safet

Multiple-Dose Pharmacokinetics and Safety of Bevirimat, a Novel Inhibitor of HIV Maturation, in Healthy Volunteers

✍ Dr David E. Martin, Robert Blum, Judy Doto, Hal Galbraith, Charles Ballow 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 130 KB